Eric Desparbes, Theravance's SVP and CFO, recently disposed of 21,426 shares of the company. The disposals took place at prices ranging from $13.04 to $13.31 per share, on dates ranging from November 20 to November 21, 2017. Desparbes still owns 321,742 shares of the company. Desparbes operates out of Brisbane, CA. Some additional info was provided as follows:
The shares were withheld by the Issuer to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity grants.
This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated December 15, 2016.
This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan da
ted September 20, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.21 to $13.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Theravance makes a similar move, sign up!
Other recent filings from the company include the following: